SPOTLIGHT: Tossing and turning? Maybe it's the Zocor

by admin |


Merck's cholesterol drug Zocor (simvastatin) may cause insomnia and other sleep disruptions, according to a new study that compared the remedy to its rival Pravachol, made by Bristol-Myers Squibb. Report

Suggested Articles

Pfizer building
Pharma

Pfizer's Vyndaqel off and running thanks to diagnosis push

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

by Eric Sagonowsky
Bavencio
Marketing

Pfizer nixes Bavencio, Inlyta-Keytruda trials

A phase 1 study of the Inlyta-Keytruda regimen, which bears a first-line nod for kidney cancer, got the ax along with several Bavencio tests.

by Angus Liu
Jakafi
Pharma

Incyte doubles down on dermatitis push with Jakafi trial win

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.

by Kyle Blankenship